Paras Healthcare’s IPO: The Difference Between Beds and Earning Capacity

Event: 15 October 2026 · Checked and explained: 17 October 2026.

Paras Healthcare’s SEBI-listed RHP filing describes an offer of up to ₹1,450 crore: a fresh issue up to ₹500 crore and an OFS up to ₹950 crore. The distinction is material because the two components have different recipients. The company does not receive the entire headline offer amount as fresh capital.

The official abridged document reports eight hospitals, 2,135 total bed capacity and 1,465 operational beds for FY26. FY26 occupancy is 61.75%, compared with 50.78% in FY25. These are different measures: the existence of a bed, its operational availability and its actual use should not be collapsed into one capacity headline.

Follow the capital split

At the disclosed maximum component sizes, fresh capital represents about 34.48% of the headline offer and OFS about 65.52%. These are arithmetic proportions of the stated components, not a confirmation of the final completed offer or its net proceeds after expenses.

For the fresh component, examine the detailed use of proceeds and implementation schedule. For the OFS component, identify the selling shareholders and the ownership change. Neither component alone answers whether the business is attractively valued.

A hypothetical ₹100 hospital offer with ₹35 of new shares does not fund ₹100 of expansion. The company’s future resources depend on its actual fresh proceeds, existing cash, borrowing and operating cash generation. This is why “large IPO” and “large new hospital investment” cannot be treated as synonyms.

A bed becomes productive through several steps

A planned bed may require construction, equipment, staffing, licences and working capital before it becomes operational. An operational bed still needs patient demand and clinical capability to generate revenue. The time between those stages affects the return on invested capital.

Imagine a fictional hospital with capacity for 200 beds but only 150 staffed and operational. If 90 of those are occupied on average, occupancy against operational beds is 60%. Dividing by the 200-bed physical capacity produces 45%, a different denominator and question.

The example is not Paras’s occupancy calculation. It shows why investors must read the source definition before comparing hospital chains or projecting revenue from capacity. A larger advertised capacity may include beds that are not yet generating income.

Occupancy and revenue per bed interact

At a simple level, inpatient revenue depends on the number of occupied bed-days and revenue earned per occupied bed-day, with the precise definition set by the company’s reporting. Growth can come from more available beds, higher utilisation or a different treatment mix.

Higher revenue per bed is not automatically pure pricing power. A more complex case mix can raise both revenue and the cost of delivering care. Changes in patient mix, geography, payer and clinical specialty can all influence the economics.

For a hypothetical hospital, 100 occupied bed-days at ₹40,000 generate ₹40 lakh under a simplified calculation. Increasing the rate to ₹44,000 raises revenue to ₹44 lakh at the same occupied days. Increasing occupied days to 110 at the old rate also produces ₹44 lakh. The growth is identical, but the operating drivers differ.

A margin improvement still needs a cash bridge

The prospectus reports FY26 operating revenue of ₹1,605.952 crore and profit of ₹43.834 crore, converted from its ₹ million units. It also presents separate EBITDA and net-profit measures. The gap between operating and final profit is a reason to examine depreciation, financing, tax and other items rather than treating an operating margin as shareholder cash.

Hospitals also have different collection arrangements. Patients, insurers and government programmes can involve different payment cycles and administrative requirements. Revenue recognition and receipt of cash may occur at different times. Growth in reported revenue therefore needs to be compared with receivables and operating cash flow.

This article does not assume a particular delay or loss rate for Paras. It identifies the financial bridge an investor should examine in the full statements and subsequent results.

Expansion can initially dilute utilisation

Opening new capacity can create a period when staffing and overhead arrive before a mature patient base. A hospital chain can therefore report strong capacity growth alongside temporarily weaker aggregate utilisation. That possibility should be assessed hospital by hospital when disclosure permits.

Conversely, rising occupancy in established facilities can improve the use of an existing cost base without requiring equivalent new capital. The economics of filling existing beds and building new ones differ. A valuation that treats both routes as identical can miss the return on the money being invested.

The useful follow-up after this filing is a consistent view of capital raised, operational capacity, occupancy, treatment mix and cash collection. The headline offer size is the opening fact; the investment story becomes clearer when the reader follows how a bed becomes a sustainable stream of earnings.

Reader questions

Does a ₹1,450 crore IPO mean Paras receives ₹1,450 crore for expansion?

No. The disclosed structure includes up to ₹500 crore fresh issue and up to ₹950 crore OFS. Selling-shareholder proceeds are different from fresh company funding.

Cover: AI-generated editorial illustration, not a photograph of the reported event. Educational analysis; examples labelled illustrative are not market quotes, forecasts or personalised investment advice.